ReviewPlants (Basel, Switzerland)2026
Toward Sustainable Paclitaxel Bioproduction: Plant Biology, Biosynthesis and Platform Engineering.
Review in Plants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paclitaxel (Taxol), a taxane diterpenoid from Taxus species, is a clinically important microtubule-stabilizing anticancer agent widely used in chemotherapy. However, its supply remains limited by precursor scarcity and the molecule's structural complexity. The biosynthetic pathway from geranylgeranyl diphosphate (GGPP) to paclitaxel is estimated to involve 19 to 23 enzymatic steps. Recent multi-omics approaches have substantially elucidated this pathway, yet key mechanistic questions persist, notably the formation of the oxetane ring. Complete heterologous biosynthesis is further hampered by poor cytochrome P450 (CYP) expression in non-native hosts and insufficient metabolic flux. This review synthesizes advances across four themes: (1) progressive elucidation of the biosynthetic pathway, with emphasis on the CYP-mediated oxygenation cascade and oxetane ring formation; (2) genomic and regulatory insights from
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.